Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 12, No. 2
February 2006

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments Comments | Email this article Email this article



References
Table

Letter

Fluoroquinolone-resistant Salmonella sp. in Carcasses

Yu-Chih Wang,* Kuang-Sheng Yeh,† Chao-Chin Chang,* Shih-Ling Hsuan,* and Ter-Hsin Chen*Comments
*National Chung Hsing University, Taichung, Taiwan; and †Taipei Medical University, Taipei, Taiwan

Suggested citation for this article


To the Editor: Fluoroquinolone (FQ)-resistant Salmonella has been isolated from patients in Taiwan (1–7). Recently, a report further indicated that several patients were infected with Salmonella enterica serovar Schwarzengrund with high-level FQ resistance (1). S. Schwarzengrund has never been isolated from food animals in Taiwan.

We report the isolation of FQ-resistant strains from pork and broiler carcasses sampled from 2000 to 2003: 27 in 2000, 3 in 2001, 4 in 2002, and 2 in 2003. These isolates made up 18.85% of the 191 Salmonella strains obtained from pork and broiler carcasses in the study period. Of these isolates, 16 FQ-resistant S. Schwarzengrund strains were further analyzed to elucidate the possible mechanism of FQ resistance. Ciprofloxacin MIC levels in these isolates ranged from 4 to 16 μg/mL, and all had high-level nalidixic acid resistance (>1,024 μg/mL). All of the 16 investigated strains displayed mutations possibly associated with high-level FQ resistance. The mutation sites included 2 sites (Ser83Phe and Asp87Gly) in the quinolone resistance–determining region (QRDR) of gyrA, 2 sites (Thr57Ser and Ser80Arg) in the QRDR of parC, and 1 site (Ser458Pro) in the QRDR of parE, respectively. Four strains had mutations in the QRDR of gyrA and parC only but not in the QRDR of parE (Table).

In conclusion, high-level FQ resistance was detected in S. Schwarzengrund isolated from pork and chicken in Taiwan. Specific mutation sites of gyrA, parC, and parE were associated with high-level FQ resistance in all the isolates investigated. Our results warrant further investigation of the public health consequences of FQ use in food animals in Taiwan.

References

  1. Baucheron S, Chaslus-Dancla E, Cloeckaert A, Chiu CH, Butaye P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob Agents Chemother. 2005;49:862–3.
  2. Chiu CH, Su LH, Hung CC, Chen KL, Chu C. Prevalence and antimicrobial susceptibility of serogroup D nontyphoidal Salmonella in a university hospital in Taiwan. J Clin Microbiol. 2004;42:415–7.
  3. Chiu CH, Wu TL, Su LH, Chu C, Chia JH, Kuo AJ, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med. 2002;346:413–9.
  4. Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000–2003. Emerg Infect Dis. 2004;10:1674–6.
  5. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Yan JJ, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis. 2004;10:60–8.
  6. Huang TM, Chang YF, Chang CF. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan. Vet Microbiol. 2004;100:247–54.
  7. Ko WC, Yan JJ, Yu WL, Lee HC, Lee NY, Wang LR, et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis. Clin Infect Dis. 2005;40:315–8.

 

Table. Characteristics of ciprofloxacin-resistant Salmonella enterica serovar Schwarzengrund strains from carcasses*†


Strain no.

Origin*

Year isolated

Antimicrobial drug resistance profile

Quinolone MICs (μg/mL)

Substitutions in QRDR‡



NAL

FLU

ENR

CIP

gyrA

parC

parE


A5

B, M

2000

CmSxtTc

1,024

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A16

P, E

2000

ApCmNSxtTc

2,048

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A17

P, E

2000

ApCmNSxtTc

2,048

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A18

P, E

2000

ApCmNSxtTc

2,048

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A19

P, E

2000

ApCmCnNSxtTc

1,024

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A20

P, E

2000

ApCmNSxtTc

2,048

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A29

B, S

2000

CmNSxtTc

1,024

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A36

B, S

2000

ApCmSxtTc

1,024

512

32

8

Ser83Phe;

Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A41

P, S

2000

ApCmCnNSxtTc

1,024

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A45

P, S

2000

ApCmNSxtTc

1,024

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

A51

P, S

2000

ApCmCnNSxtTc

1,024

512

16

4

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

A56

B, M

2000

ApCmCnNSxtTc

2,048

512

64

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

A61

P, S

2000

CmSxtTc

1,024

512

32

8

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

A62

P, S

2000

ApCmCnSxtTc

2,048

512

64

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

B16

P, E

2001

ApCmCnCroTc

2,048

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro

B73

P, N

2003

ApCmCnNSxtTc

2,048

512

32

16

Ser83Phe;
Asp87Gly

Thr57Ser;
Ser80Arg

Ser458Pro


*QRDR, quinolone resistance–determining region; B, broiler; M, middle Taiwan; P, pork; E, east Taiwan; S, south Taiwan; N, north Taiwan.

†Antimicrobial agents are ampicillin (Ap), chloramphenicol (Cm), ciprofloxacin (CIP), enrofloxacin (ENR), flumequine (FLU), gentamicin (Cn), ceftriaxone (Cro), nalidixic acid (NAL),neomycin (N), trimethoprim/sulfamethoxazole (Sxt), and tetracycline (Tc).

‡No gyrB substitutions were detected.

 

Suggested citation for this article:
Wang Y-C, Yeh K-S, Chang C-C, Hsuan S-L, Chen T-H. Fluoroquinolone-resistant Salmonella sp. in carcasses [letter]. Emerg Infect Dis [serial on the Internet]. 2006 Feb [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol12no02/05-0629.htm

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Ter-Hsin Chen, The Graduate Institute of Veterinary Public Health, College of Veterinary Medicine, National Chung Hsing University, No. 250, Kuo Kuang Rd, Taichung 402, Taiwan; fax: 886-4-2285-2186; email: thc@mail.vm.nchu.edu.tw

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted January 3, 2006
This page last reviewed January 26, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention